Zimmer Holdings, Inc. (NYSE and SIX: ZMH) announced today the debut of a new mobile app designed to serve as a feature-rich resource for patients of its Gel-One® Hyaluronate product.
For those experiencing knee pain, the Gel-One Patient App from Zimmer provides valuable information about the causes of knee pain and helps them understand more about the potential of Gel-One Hyaluronate as a safe and simple non-surgical treatment option. For those who have had a Gel-One Hyaluronate injection or are looking to get one, the app offers a number of features, including educational resources on Gel-One Hyaluronate, a location-based surgeon finder, and a pain tracker that enables patients to record their pain level on a daily basis.
"Just like the Gel-One product itself, this app is about empowering patients and helping them learn more about the outstanding non-surgical options at their disposal," said Seth Middleton, Director, Sales and Marketing, Early Intervention. "By providing a simple user interface and the ability to track pain and activity levels, the new Gel-One Patient App can give patients a streamlined and centralized experience – and help them better understand how Gel-One Hyaluronate works."
The Gel-One Patient App is out today and available in both the Apple iTunes App Store and the Google Play Store.
Graphene breakthrough offers hope against antibiotic-resistant infections